Muntaser S. Ahmad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Muntaser S. Ahmad has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Hjouj
Department of Medical Imaging, Al-Quds University, Palestine
8 shared publications Hjouj Mohammad
5 shared publicationsOsama Makhamrah
4 shared publications- Sanaa G. Alkhatib
Palestine Ahliya University
3 shared publications Ahmad Shukri
2 shared publicationsAkram Amro
Physiotherapy Department Faculty of Health Professions Al‐Quds University Jerusalem Palestine
2 shared publications
Latest Publications
- 13 July 2026
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 249
Impact of Calibration Factor Variability on Thyroid Scan Diagnosis and Accurate Dose Amount Prediction
- 13 July 2026
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 249
Impact of Calibration Factor Variability on Thyroid Scan Diagnosis and Accurate Dose Amount Prediction
- 1 January 2025
- Published by Sakun Publishing House
Formulation of Topical Microemulsion of Pregabalin for the Management of Neuropathic Pain
Pregabalin, a medication with anticonvulsant properties, is used to manage epilepsy as well as alleviate neuropathic pain linked to diabetic peripheral neuropathy and post-herpetic neuralgia is commonly treated with pregabalin. Pfizer markets pregabalin under the brand name Lyrica® in various formulations including capsules, oral solution, and extended-release tablets. Although it is beneficial, it can have adverse consequences, particularly on kidney function. This study aims to address challenges associated with oral delivery by formulating a pregabalin microemulsion for topical application. Additionally, the study investigates the impact of the surfactant/cosurfactant ratio on the phase behavior of the microemulsion. The experimental focus was on constructing pseudo-ternary phase diagrams using aqueous titration. The formation of microemulsions was achieved by combining 0.1 M pregabalin at the aquatics phase, oleic acid, IPM, and R (+)-Limonene oil at the oily phase, which also acted as penetration enhancers, along with PG in different proportions. The formulation had different concentrations of Tween 80 and ethanol, which were used as surfactants and cosurfactants. The results indicated that microemulsion formulations had the potential to serve as a substitute for oral pregabalin. Increased surfactant concentrations resulted in a larger microemulsion area compared to the levels of cosurfactant. An isotropic zone was produced more effectively using a 2:1 ratio of surfactant to cosurfactant, as compared to a 1:1 ratio. Nevertheless, when the quantity of surfactant decreased, the surfactant/cosurfactant blend exhibited reduced efficacy.
- 1 January 2025
- Published by Sakun Publishing House
Formulation of Topical Microemulsion of Pregabalin for the Management of Neuropathic Pain
Pregabalin, a medication with anticonvulsant properties, is used to manage epilepsy as well as alleviate neuropathic pain linked to diabetic peripheral neuropathy and post-herpetic neuralgia is commonly treated with pregabalin. Pfizer markets pregabalin under the brand name Lyrica® in various formulations including capsules, oral solution, and extended-release tablets. Although it is beneficial, it can have adverse consequences, particularly on kidney function. This study aims to address challenges associated with oral delivery by formulating a pregabalin microemulsion for topical application. Additionally, the study investigates the impact of the surfactant/cosurfactant ratio on the phase behavior of the microemulsion. The experimental focus was on constructing pseudo-ternary phase diagrams using aqueous titration. The formation of microemulsions was achieved by combining 0.1 M pregabalin at the aquatics phase, oleic acid, IPM, and R (+)-Limonene oil at the oily phase, which also acted as penetration enhancers, along with PG in different proportions. The formulation had different concentrations of Tween 80 and ethanol, which were used as surfactants and cosurfactants. The results indicated that microemulsion formulations had the potential to serve as a substitute for oral pregabalin. Increased surfactant concentrations resulted in a larger microemulsion area compared to the levels of cosurfactant. An isotropic zone was produced more effectively using a 2:1 ratio of surfactant to cosurfactant, as compared to a 1:1 ratio. Nevertheless, when the quantity of surfactant decreased, the surfactant/cosurfactant blend exhibited reduced efficacy.
- 8 December 2024
- Published by Springer Nature
- p. 1443-1455
Assessing Radiation Dose Levels in Aortic CT Imaging: A Comparative Analysis of DLP and CTDI References in Palestinian Governmental Hospitals
- 8 December 2024
- Published by Springer Nature
- p. 1443-1455
Assessing Radiation Dose Levels in Aortic CT Imaging: A Comparative Analysis of DLP and CTDI References in Palestinian Governmental Hospitals
- 8 December 2024
- Published by Springer Nature
- p. 735-748
Evaluation of Radiation Doses of the 18FDG PET/CT in the Whole Body and Midthigh Protocols for Oncologic Patients
- 8 December 2024
- Published by Springer Nature
- p. 735-748
Evaluation of Radiation Doses of the 18FDG PET/CT in the Whole Body and Midthigh Protocols for Oncologic Patients
- 8 December 2024
- Published by Springer Nature
- p. 429-441
Treatment Responses in Hodgkin and Non-Hodgkin Lymphoma Through the Lens of FDG PET/CT Imaging
- 8 December 2024
- Published by Springer Nature
- p. 429-441
Treatment Responses in Hodgkin and Non-Hodgkin Lymphoma Through the Lens of FDG PET/CT Imaging
- 27 September 2024
- Published by Wiley in Physiotherapy Research International
- Vol. 29 (4) , e2136
The effect of physiotherapy intervention on functional outcomes among COVID‐19 patients: Clinical experimental study
Background: COVID‐19 is a highly contagious virus that causes pneumonia, which quickly progresses to acute respiratory distress. In the case of COVID‐19, physiotherapy is critical in non‐invasive support management, postural changes, chest physiotherapy (CPT), and bed mobility. This study aims to look into the effects of physiotherapy intervention on functional outcome levels in COVID‐19 patients in the acute stage.Methods: A total of 60 severe COVID‐19 patients (54 males and 6 females) with a mean age of 50 years were studied. The intervention group (n = 30) had two daily physiotherapy sessions that included positioning, CPT, cardio exercises, breathing exercises, and early mobility, whereas the control group (n = 30) received only standard medical care. Patients were tested twice at the baseline and discharge using peripheral oxygen saturation, respiratory rate (RR) test, dyspnea rate, two‐min walk test, and spirometer scores, forced vital capacity (FVC) and forced expiratory volume in one second (FEV1).Results: The two groups improved significantly between the baseline and discharge ratings. The intervention group, on the other hand, significantly improved all outcome indicators at discharge (p‐value = 0.00). This study found that physiotherapy management improved oxygen saturation, RR, dyspnea, and lung function tests in COVID‐19 patients except in FVC (p‐value = 0.402) and FEV1(p‐value = 0.114).Conclusion: Physiotherapist interventions with COVID‐19 patients increase respiratory function and treatment time.
- 27 September 2024
- Published by Wiley in Physiotherapy Research International
- Vol. 29 (4) , e2136
The effect of physiotherapy intervention on functional outcomes among COVID‐19 patients: Clinical experimental study
Background: COVID‐19 is a highly contagious virus that causes pneumonia, which quickly progresses to acute respiratory distress. In the case of COVID‐19, physiotherapy is critical in non‐invasive support management, postural changes, chest physiotherapy (CPT), and bed mobility. This study aims to look into the effects of physiotherapy intervention on functional outcome levels in COVID‐19 patients in the acute stage.Methods: A total of 60 severe COVID‐19 patients (54 males and 6 females) with a mean age of 50 years were studied. The intervention group (n = 30) had two daily physiotherapy sessions that included positioning, CPT, cardio exercises, breathing exercises, and early mobility, whereas the control group (n = 30) received only standard medical care. Patients were tested twice at the baseline and discharge using peripheral oxygen saturation, respiratory rate (RR) test, dyspnea rate, two‐min walk test, and spirometer scores, forced vital capacity (FVC) and forced expiratory volume in one second (FEV1).Results: The two groups improved significantly between the baseline and discharge ratings. The intervention group, on the other hand, significantly improved all outcome indicators at discharge (p‐value = 0.00). This study found that physiotherapy management improved oxygen saturation, RR, dyspnea, and lung function tests in COVID‐19 patients except in FVC (p‐value = 0.402) and FEV1(p‐value = 0.114).Conclusion: Physiotherapist interventions with COVID‐19 patients increase respiratory function and treatment time.
- 30 June 2024
- Published by Palestine Ahliya University in Ahliya Journal of Allied Medico-Technology Science
- Vol. 1 (1) , 36-44
Performance Metrics Comparison of CT with PET/CT Reports in Lymphoma Patient Follow-Up
The incidence of Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) is rising annually, necessitating effective monitoring strategies. Computed Tomography (CT) and Positron Emission Tomography/Computed Tomography (PET/CT) are pivotal in this regard but differ in diagnostic accuracy due to their distinct imaging capabilities. This retrospective study evaluates 56 lymphoma patients using both modalities at Al-Ahli Hospital, Hebron, Palestine, from 2020 to 2023. Demographic and clinical data, alongside imaging findings, were analyzed. Results indicate PET/CT's superiority over CT alone, with higher sensitivity, specificity, precision, Accuracy where CT findings were 20%, 30.61%, 0.72%, and 30.34% retrospectively compared with PET/CT findings. Gender-specific analysis revealed marginal associations, highlighting the need for tailored imaging strategies. The study underscores PET/CT's enhanced diagnostic performance in lymphoma surveillance, advocating its use for improved patient management and outcomes. Further research could refine these findings, addressing the evolving landscape of lymphoma imaging.
- 30 June 2024
- Published by Palestine Ahliya University in Ahliya Journal of Allied Medico-Technology Science
- Vol. 1 (1) , 36-44
Performance Metrics Comparison of CT with PET/CT Reports in Lymphoma Patient Follow-Up
The incidence of Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) is rising annually, necessitating effective monitoring strategies. Computed Tomography (CT) and Positron Emission Tomography/Computed Tomography (PET/CT) are pivotal in this regard but differ in diagnostic accuracy due to their distinct imaging capabilities. This retrospective study evaluates 56 lymphoma patients using both modalities at Al-Ahli Hospital, Hebron, Palestine, from 2020 to 2023. Demographic and clinical data, alongside imaging findings, were analyzed. Results indicate PET/CT's superiority over CT alone, with higher sensitivity, specificity, precision, Accuracy where CT findings were 20%, 30.61%, 0.72%, and 30.34% retrospectively compared with PET/CT findings. Gender-specific analysis revealed marginal associations, highlighting the need for tailored imaging strategies. The study underscores PET/CT's enhanced diagnostic performance in lymphoma surveillance, advocating its use for improved patient management and outcomes. Further research could refine these findings, addressing the evolving landscape of lymphoma imaging.
- 30 June 2024
- Published by Palestine Ahliya University in Ahliya Journal of Allied Medico-Technology Science
- Vol. 1 (1) , 9-14
A Novel Timing Equation for Predicting Optimal Contrast Medium Enhancement in Abdomen CT Scan Procedure
Abdominal CT (Computed Tomography) scans are crucial for diagnosing a wide range of abdominal conditions by providing detailed images of the abdominal organs. The aim of this study is to develop and validate a novel timing equation for predicting optimal contrast medium enhancement in abdominal CT procedures. Utilizing a quantitative research design, data was retrospectively collected from 155 patients who underwent CT scans with contrast media, focusing on variables such as age, gender, weight, creatinine levels, and injection parameters. Statistical analysis, including multi-linear regression and ANOVA, was conducted to derive predictive equations for arterial, venous, and delayed times. The results indicated that Location of the cannula significantly influence arterial time, age is significantly influence venous enhancement time, while weight was the only significant predictor of delayed time, demonstrating the need for patient-specific timing in CT scans. In conclusion, the proposed timing equation could enhance diagnostic accuracy and patient care by optimizing contrast enhancement in abdominal CT procedures.
- 30 June 2024
- Published by Palestine Ahliya University in Ahliya Journal of Allied Medico-Technology Science
- Vol. 1 (1) , 9-14
A Novel Timing Equation for Predicting Optimal Contrast Medium Enhancement in Abdomen CT Scan Procedure
Abdominal CT (Computed Tomography) scans are crucial for diagnosing a wide range of abdominal conditions by providing detailed images of the abdominal organs. The aim of this study is to develop and validate a novel timing equation for predicting optimal contrast medium enhancement in abdominal CT procedures. Utilizing a quantitative research design, data was retrospectively collected from 155 patients who underwent CT scans with contrast media, focusing on variables such as age, gender, weight, creatinine levels, and injection parameters. Statistical analysis, including multi-linear regression and ANOVA, was conducted to derive predictive equations for arterial, venous, and delayed times. The results indicated that Location of the cannula significantly influence arterial time, age is significantly influence venous enhancement time, while weight was the only significant predictor of delayed time, demonstrating the need for patient-specific timing in CT scans. In conclusion, the proposed timing equation could enhance diagnostic accuracy and patient care by optimizing contrast enhancement in abdominal CT procedures.
- Open Access
- 9 November 2023
- Published by Association for Computing Machinery (ACM)
- p. 103-110
Imaging Modality Contribution of Radiation dose from PET/CT Procedures in Palestinian Hospitals
PET/CT hybrid technology exposes patients to additional radiation. This study aims to determine organ and effective dosage values for patients, evaluate gender dose differences, and determine the contribution of CT and PET to the final dose. Five CT protocols were utilized to reference PET/CT images in this investigation. The device's CTDIv and DLP readings with all parameters for both genders were compared to CT-Expo dosimetry findings. The PET doses were estimated using ICRP 106 dosage coefficients. Results demonstrated considerable disparities between device and CT-Expo readings. CT-Expo program values exceeded device values, and female mean equivalent doses were 6–17% higher than male values. 18F-FDG contributed 10–15% to the overall dosage for men and 12–15% for females. CT accounts for 85–90% and 85-88% of the patient's ultimate dosage for men and women. CT methods that minimize patient radiation without compromising picture quality should be used. This should be emphasized for females.
- 9 November 2023
- Published by Association for Computing Machinery (ACM)
- p. 103-110
Open AccessImaging Modality Contribution of Radiation dose from PET/CT Procedures in Palestinian Hospitals
PET/CT hybrid technology exposes patients to additional radiation. This study aims to determine organ and effective dosage values for patients, evaluate gender dose differences, and determine the contribution of CT and PET to the final dose. Five CT protocols were utilized to reference PET/CT images in this investigation. The device's CTDIv and DLP readings with all parameters for both genders were compared to CT-Expo dosimetry findings. The PET doses were estimated using ICRP 106 dosage coefficients. Results demonstrated considerable disparities between device and CT-Expo readings. CT-Expo program values exceeded device values, and female mean equivalent doses were 6–17% higher than male values. 18F-FDG contributed 10–15% to the overall dosage for men and 12–15% for females. CT accounts for 85–90% and 85-88% of the patient's ultimate dosage for men and women. CT methods that minimize patient radiation without compromising picture quality should be used. This should be emphasized for females.